Justin Rutt, DO
Neuromusculoskeletal Medicine & OMM · East Lansing, MINPI 1578950804
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Otsuka America Pharmaceutical, Inc. at 24.3% of the total.
Across 16 payments — averaging $19.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$75
- AstraZeneca$57
- AbbVie$48
- Pfizer$42
- Axsome Therapeutics, Inc.$25
- Novo Nordisk$21
- plus $40 from 2 others
What the payments were for
- Food & beverage$308100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $75 |
| AstraZeneca | 3 | $57 |
| AbbVie | 3 | $48 |
| Pfizer | 2 | $42 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Novo Nordisk | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Merck | 1 | $20 |
How this compares
$308 in reported general payments places this provider in the 75th percentile of 41 neuromusculoskeletal medicine & omm providers in Michigan.
See all neuromusculoskeletal medicine & omm providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 85 | $110,413 |
| TrulicityDulaglutide | 53 | $84,957 |
| MounjaroTirzepatide | 44 | $60,996 |
| OzempicSemaglutide | 45 | $59,751 |
| EliquisApixaban | 35 | $44,067 |
| FarxigaDapagliflozin Propanediol | 16 | $24,389 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $21,415 |
| JanuviaSitagliptin Phosphate | 15 | $15,711 |
| XareltoRivaroxaban | 14 | $15,142 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 23 | $7,449 |
| Spiriva HandihalerTiotropium Bromide | 12 | $6,383 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 22 | $4,973 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 12 | $4,416 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 91 | $3,673 |
| Duloxetine Hcl | 114 | $2,740 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $20 | $145,95397 claims |
| Novo NordiskOzempic | $21 | $59,75145 claims |
| PfizerEliquis, Abrysvo | $42 | $51,51658 claims |
| AstraZenecaFarxiga | $57 | $24,38916 claims |
| MerckJanuvia | $20 | $15,71115 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 41 neuromusculoskeletal medicine & omm providers in Michigan.
Other neuromusculoskeletal medicine & omm in East Lansing
- Reddog SinaEast Lansing$1K
- Zachary WilsonEast Lansing$448
- Maxwell RouseEast Lansing$128
- Clarence NicodemusEast Lansing$104
- Nathan BarnhurstEast Lansing$94
- Kathleen StenlundEast Lansing$69
- Joshua ThompsonEast Lansing$60
- Christopher HannaschEast Lansing$55
- Justine Tran-SerranoEast Lansing$47
- Zachary ShiverEast Lansing$22
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.